Rankings
▼
Calendar
NAUT
Nautilus Biotechnology, Inc.
$339M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$19M
Net Income
-$16M
EPS (Diluted)
$-0.13
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$318M
Total Liabilities
$41M
Stockholders' Equity
$277M
Cash & Equivalents
$74M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
$0
—
Operating Income
-$19M
-$16M
-20.6%
Net Income
-$16M
-$14M
-12.9%
← FY 2023
All Quarters
Q4 2023 →
NAUT Q3 2023 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena